Word: leukemias
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
DIED. KENNETH KOCH, 77, effervescent founding member, with John Ashbery and Frank O'Hara, of the 1950s' New York school of poets; of leukemia; in New York City. Famous for his boisterous, erudite and often erotic verse, Koch rejected the somber literariness of predecessors such as T.S. Eliot and Ezra Pound. He infused his 20 volumes with lyrical improvisations and exuberant homages to such items as business letterheads, furniture, lipstick and fudge...
...singed off his arms, back and buttocks. His grandfather treated his burns with cooking oil for two years before Taniguchi was able to resume his job as a mail carrier. The museum also has video testimonies from other victims, among them an American woman whose sister was stricken with leukemia following nuclear testing near the family's home in the U.S.?a reminder that in the nuclear age, no one is safe...
...sick kid. We all knew this, so when he laughed at his own jokes, which were rusty way before I had him, we laughed too, forcing it sometimes just to make him happy. His daughter died a year and a half after I did. She had leukemia, but I never saw her in my heaven...
...dramatically. The first was the death of my sister Barbara. This was in 1981; she was 38 years old. Prior to that, I had taken everything for granted. It was the late '70s, and everything was coming my way. I was riding high. When I lost my sister to leukemia, I was completely devastated and traumatized. Barbara was my best friend and basically the only person I was afraid of. She was a bit of a dictator with me. But she had her door open to everyone; she was always trying to help people. She would say to me, "What...
...they should. Yet this belief needs to be scrutinized by unbiased scientists working in the patients' interest. Our trials can never be too safe. But we should not lose sight of the fact that our system has given rise to spectacular advances in cancer therapy, including Gleevec for leukemia; the control of aids; treatments for breast cancer; and others. As a new era of molecular genetic research dawns, we need to make certain that the strides we make in devising new therapies are matched by progress in ensuring patient safety. FRANK G. HALUSKA, M.D., PH.D. Director, Melanoma Program Massachusetts General...